Clinical Trial: A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label, Randomized, Parallel-group, Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 133 Administered Subcutaneously in Chinese Subjects With Obesity
Brief Summary:
The main objective of the study is to assess the pharmacokinetics (PK) of Maridebart Cafraglutide after a single subcutaneous (SC) administration in overweight or obese Chinese participants.
Read more